Annabelle’s Challenge is a UK registered charity with a brave little girl at its heart; eight-year-old Annabelle Griffin. Annabelle was diagnosed with.

Slides:



Advertisements
Similar presentations
© 2009 NHS National Genetics Education and Development CentreGenetics and Genomics for Healthcare This PowerPoint file contains.
Advertisements

Role of clinical genetics in medicine. Who provides this service Varies depending on structure and funding of service but is in reality provided by many.
Healthcare in the UK Margaret Costello – Gorlin Syndrome Group.
THE ROLE OF ALZHEIMER ASSOCIATIONS IN CAMPAIGNING FOR CHANGE Marc Wortmann Alzheimer’s Disease International.
Corrine Fillman, M.S., C.G.C. Connective Tissue Gene Tests (CTGT) 6580 Snowdrift Road, Suite 300 Allentown, PA
Ensuring the Quality of Genetic Testing ICORD Meeting September 14, 2007 Lisa Kalman, PhD Coordinator, GeT-RM CDC
Cancer in Our Genes International Patient Database A patient-driven database dedicated to finding a cure for VHL and other cancers.
Vascular Ehlers-Danlos syndrome: Placing recent studies into context Mitzi L. Murray, MD, MA EDNF Annual Learning Conference August 10, 2012.
Research Repository for Heritable Disorders University of Washington - Department Pathology Peter Byers, MD Ulrike Schwarze, MD Melanie Pepin, MS, CGC.
Marfan Syndrome Also known as Arachnodactyly, MFS, & Marfan Syndrome Type 1 and Type 2 By: Kianna Thompson.
Ehlers-Danlos Syndrome Jenn Huff PESS 462 Dr. Ruth Nearing.
Osteogenesis Imperfecta
Ehlers-Danlos Syndromes Emily Chang AM report May 18, 2009.
Diabetes Aspects of the Local Enhanced Service Dr Mark Barrett Dr Jeremy Sandford Dr Aythen Elkindi.
A 4 year old girl presenting with short stature Teaching NeuroImages Neurology Resident and Fellow Section © 2014 American Academy of Neurology.
Ehlers-Danlos Syndrome. Ehlers-Danlos Syndromes  A group of separate conditions  You cannot pass on a type you don’t have  Currently 7 types recognised.
CMD International Registry CMD Family Conference August 2010 Ami Mehta, MS, CGC
Talking to Your Family About Your Diagnosis of Hereditary Breast and Ovarian Cancer Syndrome Several of my aunts died of breast cancer, so I was very worried.
The Ehlers-Danlos Support UK
Ehlers-Danlos Syndrome. What will we be covering? What is Ehlers-Danlos syndrome Diagnosis How does this affect people day to day? Support.
Annabelle’s Challenge Charity Annabelle’s Challenge is a local UK registered charity with a brave little girl from Bury at its heart; six-year-old Annabelle.
By: Alaina Zsampar MARFAN SYNDROME.  Disorder that affects the body’s connective tissues  1896  By French Doctor Antoine Marfan  Observed a five year.
The Ehlers-Danlos Support UK Area Coordinator
PSA Consensus and The Prostate Cancer Risk Management Programme Karen Stalbow, Prostate Cancer UK Dr Ali Cooper, Prostate Cancer UK Annual Conference 2016.
Genes in Life is a place to learn about all the ways genetics is a part of your life. On this site you will learn:   How.
European Patients’ Academy on Therapeutic Innovation Challenges in Personalised Medicine.
Hereditary Cancer Predisposition: Updates in Genetic Testing
Produced by Wessex LMCs
The Guardian Project Safeguarding and supporting Girls affected by fgm
Genetic Testing in Human: The Clinician’s Perspective ncbi
Marfan Syndrome Melanie Dragomire Dr. Williams NS215
Monogenic Disorders Genetic Counselling
SYMPTOMS Fragile X Chromosome WHAT IS THE FRAGILE X SYNDROME?
Dementia Learning Session
Development of a next-generation sequencing gene panel for neurogenetic disorders J E Martindale, R Crookes, L Crooks, N J Beauchamp, A Dalton Sheffield.
Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Saleh Albanyan, Rachel Giles, Raymond H Kim, MD/PhD Division of.
Clinical Nurse Specialist in Paediatric Endocrinology
Results from a survey of UK patients at risk of bowel cancer, their experiences and information preferences. Selina Goodman, Heather Skirton, Ray Jones.
11 m with nephrotic range proteinuria
Marfan’s Syndrome By Emily Espinosa.
Asmaa Hmaid Esraa Shbair
What are reduced penetrance and variable expressivity
Li-Fraumeni Syndrome Wendy Kohlmann, MS, CGC
Jody Blake Wolfram Syndrome Family Coordinator
Hypermobility (and a little on inherited collagen disorders)
Budapest, Hungary - September 17-19, 2015
WHY GENETIC COUNSELING IS IMPORTANT
Genetic Testing Result Means. Before Genetic Testing  The result of genetic testing can be life changing.  It is important for patients and their families.
Who in the room would offer BRCA1/2 testing to this patient Who in the room would offer BRCA1/2 testing to this patient? How might the medical management.
The Ehlers-Danlos Support UK
Colin Sloane - Quality Improvement Lead Yorkshire and the Humber
CONNECTIVE TISSUE DISORDERS
Epidermolysis Bullosa
Lorraine Hartles West Midlands Regional Genetics Laboratory
West Midlands Regional Genetics Laboratory
Genetic Testing.
Human Genetic Disorders Part 3
DiagMMR™ assay validation sample collection
Genetic Cancer Screening
Class Notes #8: Genetic Disorders
Genetics made easy: demystifying genetic testing
TITLE TEXT.
Temporal-Spatial Gait Characteristics in Youths with Hypermobile Ehlers-Danlos By: Nicole Vigon.
HOW A RETINAL PATIENT GROUP CAN INFLUENCE GENOTYPING IN A DEVELOPING COUNTRY RI Conference , Stresa, 2010.
Breast Cancer BRCA testing protocol
Breast cancer BRCA testing protocol
Genetic Testing for RP. Case Study of the UK
Dementia: Barriers to accessing quality End of Life Care and Role of Admiral Nurses Chris O’Connor Consultant Admiral Nurse Dementia Fellow   
Presentation transcript:

Annabelle’s Challenge is a UK registered charity with a brave little girl at its heart; eight-year-old Annabelle Griffin. Annabelle was diagnosed with Vascular Ehlers-Danlos Syndrome (Vascular EDS) in December 2012 aged three. Vascular EDS is a life threatening and incurable genetic condition.

Annabelle’s Challenge - Our journey so far Dec 2012 Annabelle diagnosed with vascular EDS Jan 2013 Annabelle’s Challenge launched Apr 2013 Media campaign May 2013 Website launched May 2014 UK Registered Charity May 2015 Conference planning with EDS Diagnostic Team May 2017 Vascular EDS Conference

What is vascular EDS? Connective tissue condition characterised by, tissue fragility, easy bruising and joint hypermobility. Vascular EDS was previously known as EDS Type IV Rare – between 1:90,000-1:250,000 >700 in UK Genetic: autosomal dominant mutation in COL3A1 gene up to 50% of individuals have new mutations COL3A1 gene codes for a protein abundant in connective tissue: type III collagen

Thin skin/Visible veins

Easy Bruising

Testing for vascular EDS Gene testing – available since 2006 in UK as service test Take a blood sample, Extract DNA, send to Sheffield lab Just look at COL3A1 gene/or do TAA panel Sensitive/specific test Pathogenic mutation gene change not found, clinically individual findings consistent with a diagnosis of vascular EDS Phenocopy of VEDS Rare mutation mechanism May get change uncertain significance Skin biopsy – samples taken in clinic using local anaesthetic – examined under a microscope

Benefits of knowing the specific gene change Confirms correct diagnosis Testing of other family members at risk Surveillance unnecessary if test negative Appropriate surveillance , test positive Pregnancy – PGD or testing during a pregnancy Different types of gene alterations: may be a way in the future of predicting severity

NHS Ehlers-Danlos Diagnostic Service

EDS National Diagnostic Service Set up in 2009 Now seen over 150 patients with vascular EDS Patients followed up over this time period From birth to nearly 70 Referrals to / from Annabelle’s Challenge

UK has a national diagnostic EDS service at two locations aimed at diagnosing the rare types of EDS who also have joint vascular clinics with cardiologists for follow-up of patients with rare types of EDS and vascular complications The national diagnostic EDS service is connected with DNA laboratory in Sheffield that specializes in DNA tests for hereditary connective tissue disorders Active patient organisations (Annabelle’s Challenge & EDS UK) that collaborate with medical professionals: this led to the UK’s first ever conference in May 2017.

Search term “vascular Ehlers Danlos syndrome” Publications per year in period 1949-2016

Plan – talk about new blue emergency wallet card for vascular EDS patients Recently developed Small enough to carry at all times Contains information for medical professionals in case of an emergency situation Publicising as we aim for all vascular EDS patients in the UK to carry the card Will explain how to get one Will also talk about how and why we developed it

How is the set-up in the UK for research in vEDS?

vEDS research in the UK UK is large: important for rare disorders prevalence could be 1:50,000: Byers et al 2017 1260 people with vEDS

Future needs Create an international web-based registry of individuals with vascular EDS with permission to contact and re-contact for both clinical information and involvement in clinical trials Provide newly diagnosed patients a support and sign posting guide

Why is involvement of people with vEDS so important? - More Insight into natural history of vEDS - Development of better management strategies - Research questions that need to be answered - Motivation for research - Funding: involvement of patients in research projects

promote international cooperation and collaboration through yearly scientific/clinical meetings in revolving venues

Vascular EDS Conference

54 Medical Professionals 50 Vascular EDS Patients 240 Conference Delegates 140 Friends, Family, Carers 54 Medical Professionals 50 Vascular EDS Patients Germany, Denmark, France, Aland, Jersey, Isle of Man, UK, Australia & USA